IMPORTANCE The diagnostic performance of the fibrosis-4 index (FIB-4) and nonalcoholic
fatty liver disease (NAFLD) fibrosis score (NFS) for advanced fibrosis in lean patients with …

Importance The most important surrogate for increased risk of adverse clinical outcomes
among patients with nonalcoholic fatty liver disease (NAFLD) is the patient's stage of liver …

METHODS: Four databases were searched until December 2020 (CRD42021224766).
Original articles reporting data on the performance of FIB-4 and NFS, interpreted according …

Background Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic
liver disease. Severe NAFLD with advanced fibrosis results in substantial morbidity and …

Background & Aims Fibrosis affects prognoses for patients with nonalcoholic fatty liver
disease (NAFLD). Several non-invasive scoring systems have aimed to identify patients at …

Background & Aims There is limited knowledge regarding the longitudinal utility of
biomarkers of fibrosis, such as the nonalcoholic fatty liver disease (NAFLD) fibrosis score …

Background There is a need for a reliable and inexpensive noninvasive marker of hepatic
fibrosis in nonalcoholic fatty liver disease (NAFLD). Aim To compare the performance of the …

BACKGROUND Identifying hepatic fibrosis is crucial for nonalcoholic fatty liver disease
(NAFLD) management. The fibrosis-8 (FIB-8) score, recently developed by incorporating …

Background Non-invasive tests are widely used to diagnose fibrosis in patients with non-
alcoholic fatty liver disease (NAFLD), however, the optimal method remains unclear. We …

Background Non-invasive scores, such as the non-alcoholic fatty liver disease (NAFLD)
Fibrosis Score (NFS), are increasingly used for liver fibrosis assessment in patients with …